Usada's Lance Armstrong rap sheetThe Guardian1 Use and/or attempted use of prohibited substances and/or methods including EPO, blood transfusions, testosterone, corticosteroids and/or masking agents. 2 Possession of prohibited substances and/or met…
Research and Markets: Bone Marrow Transplantation – Pipeline Review, H2 2012 – The Herald | HeraldOnline.com
Research and Markets: Bone Marrow Transplantation – Pipeline Review, H2 2012The Herald | HeraldOnline.comDUBLIN — Research and Markets (http://www.researchandmarkets.com/research/glrzv3/bone_marrow) has announced the addition of Global Markets Direct…
BUSINESS WIRE: Biogen Idecs Engagement für multiple Sklerose auf 28 … – Vereinigte Wirtschaftsdienste
BUSINESS WIRE: Biogen Idecs Engagement für multiple Sklerose auf 28 …Vereinigte WirtschaftsdiensteDaclizumab High-Yield Process (DAC HYP) ist eine subkutan verabreichte Formulierung von Daclizumab im fortgeschrittenen Stadium der klinischen Entwickl…
Biogen Idecs Engagement für multiple Sklerose auf 28. ECTRIMS-Kongress … – Live-PR.com (Pressemitteilung)
Biogen Idecs Engagement für multiple Sklerose auf 28. ECTRIMS-Kongress …Live-PR.com (Pressemitteilung)The effect of daclizumab HYP on sustained disability progression in the SELECT trial (Der Einfluss von Daclizumab HYP auf das anhaltende Fortschrei…
BUSINESS WIRE: Biogen Idecs Engagement für multiple Sklerose auf 28 … – Finanztreff
BUSINESS WIRE: Biogen Idecs Engagement für multiple Sklerose auf 28 …FinanztreffDaclizumab High-Yield Process (DAC HYP) ist eine subkutan verabreichte Formulierung von Daclizumab im fortgeschrittenen Stadium der klinischen Entwicklung für die Thera…
IRF 2012: When the legend speaks… – indiaretailing.com
IRF 2012: When the legend speaks…indiaretailing.comTwo of the legends of modern Indian retail R Subramanian and B S Nagesh came together at the India Retail Forum 2012 (IRF) for a frank and heart-to-heart discussion. Subbu, as he's fondly called,…
Veloxis Pharmaceuticals to Present Data Differentiating LCP-Tacro™ from … – Sacramento Bee
Veloxis Pharmaceuticals to Present Data Differentiating LCP-Tacro™ from …Sacramento BeeHORSHOLM, Denmark, Oct. 10, 2012 — /PRNewswire/ — Veloxis will give two upcoming data presentations that further define the profile of LCP-Tacro compared to ot…
Undertrial beaten to death – Business Standard
Undertrial beaten to deathBusiness StandardThe postmortem of Sarfuddin by a panel of two doctors last night found that his liver and ribs were damaged, besides a injury on the body suggesting that he was assaulted inside the jail, official sources said…
Women respond much better than men to treatment of CFL with rituximab – News-Medical.net
Women respond much better than men to treatment of CFL with rituximabNews-Medical.netWomen respond much better than men to the treatment of chronic follicular lymphoma with a monoclonal antibody that targets CD20 (rituximab). These are the findings of …
Campaign looking for 1000 Plymouth people to become organ donors – This is Plymouth
This is PlymouthCampaign looking for 1000 Plymouth people to become organ donorsThis is PlymouthHerald editor Ian Wood said: "We are hoping to give the Organ Donor Register a boost by working with Plymouth Hospitals NHS Trust to get another 1,000 …
